A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Elevated cyclooxygenase-2 (COX-2) expression is linked to chronic inflammation and cancer.
• Mechanisms driving pathogenic COX-2 overexpression remain largely unknown.
• The PTGS2 gene harbors a T8473C single-nucleotide polymorphism (SNP) associated with COX-2-related diseases.

Purpose of the Study:

• To elucidate the molecular mechanisms behind COX-2 overexpression.
• To investigate the role of the T8473C SNP in COX-2 regulation.
• To identify potential diagnostic markers for disease susceptibility and treatment.

Main Methods:

• MicroRNA-mediated regulation analysis of COX-2 mRNA.
• Identification of microRNA binding sites and their impact on mRNA stability.
• Allele-specific expression analysis in colon cancer cells and tissues.

Main Results:

• The T8473C SNP is located in a microRNA-regulated region of COX-2 mRNA.
• miR-542-3p binds to the 8473T allele, promoting mRNA decay.
• The 8473C allele impedes miR-542-3p binding, leading to mRNA stabilization and COX-2 overexpression.
• Colon cancer exhibits COX-2 mRNA levels dependent on T8473C allele dosage.

Conclusions:

• The T8473C SNP influences COX-2 expression via altered microRNA binding and mRNA stability.
• This provides a molecular basis for disease susceptibility associated with the COX-2 T8473C SNP.
• The T8473C SNP may serve as a marker for selecting patients for COX-2 inhibitor therapy.